The giant will purchase a biotech company with cannabinoid-type therapeutics in the pipeline. Pharmaceutical giant Pfizer Inc. is entering the cannabis space via the $6.7 billion acquisition of Arena Pharmaceuticals, Inc. The two publicly-traded companies confirmed Monday that they have signed a definitive agreement under which Pfizer will acquire all outstanding shares of Arena for $100 per share in an all-cash transaction. Pfizer expects to … Continue reading Pfizer Is the Next Big Pharma Company Entering the Cannabis Space
The post Pfizer Is the Next Big Pharma Company Entering the Cannabis Space first appeared on Lawstarz.↧